Literature DB >> 3264798

Human testis cytosol and ovarian follicular fluid contain high amounts of interleukin-1-like factor(s).

S A Khan1, K Schmidt, P Hallin, R Di Pauli, C De Geyter, E Nieschlag.   

Abstract

Human testicular cytosol and ovarian follicular fluid were analyzed for the presence of interleukin-1 (IL-1)-like factors. Both the follicular fluid and testis cytosol preparations exhibited significant IL-1-like activity as determined by the murine thymocyte proliferation bioassay. The dose-response lines obtained with the gonadal preparations were parallel to each other and to those obtained with monocyte-derived IL-1 and the activity of the gonadal IL-1 could be neutralized by specific IL-1 antibodies. After gel chromatography of human follicular fluid (hFF) and human testis cytosol (hTC) proteins, IL-1 activity was found in the molecular weight region between 30 and 50 kilodaltons (kDa). Chromatofocusing of IL-1 from hFF and hTC revealed that the major part of IL-1 in both cases exhibited similar charge properties (pI less than 6.0). However, two extra peaks (pI 7.0 and greater than 9.0, respectively) were observed in hFF preparations. After isoelectrofocusing (IEF), IL-1 activity of hFF was also found in two different pH regions; a broad area of activity was localized between pH 5.5 and 7.0, while a sharp peak was observed with an approximate pI value of 9.5. Re-chromatofocusing or IEF of alkaline IL-1-like activity resulted in a heterogeneous profile of IL-1-like activity suggesting that the alkaline material may represent either a precursor or an aggregated form of the acidic IL-1. None of the IL-1 peaks obtained from hFF or hTC exhibited IL-2 activity as assessed in a specific IL-2 bioassay. The results of the present study indicate that both gonads may produce high amounts of IL-1-like factor(s) which might play a regulatory role in normal gonadal function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264798     DOI: 10.1016/0303-7207(88)90158-x

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

Review 1.  Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?

Authors:  Milica Popovic; Gideon Sartorius; Mirjam Christ-Crain
Journal:  Semin Immunopathol       Date:  2019-05-28       Impact factor: 9.623

2.  Giants in Obstetrics and Gynecology Series: a profile of Mary Lake Polan, PhD, MD, MPH.

Authors:  Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2022-02       Impact factor: 8.661

3.  Evidence that granulosa cells inhibit interleukin-1 alpha and interleukin-2 production from follicular lymphomonocytes.

Authors:  A Macciò; G Mantovani; E Turnu; P Artini; G Contu; F G Serri; A Volpe
Journal:  J Assist Reprod Genet       Date:  1993-11       Impact factor: 3.412

4.  Human intraovarian interleukin-1 (IL-1) system: highly compartmentalized and hormonally dependent regulation of the genes encoding IL-1, its receptor, and its receptor antagonist.

Authors:  A Hurwitz; J Loukides; E Ricciarelli; L Botero; E Katz; J M McAllister; J E Garcia; R Rohan; E Y Adashi; E R Hernandez
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

5.  Nitric oxide mediates interleukin-1-induced cellular cytotoxicity in the rat ovary. A potential role for nitric oxide in the ovulatory process.

Authors:  C Ellman; J A Corbett; T P Misko; M McDaniel; K P Beckerman
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

6.  Interleukin-1 (IL-1) system gene expression in granulosa cells: kinetics during terminal preovulatory follicle maturation in the mare.

Authors:  Alain Martoriati; Nadine Gérard
Journal:  Reprod Biol Endocrinol       Date:  2003-05-16       Impact factor: 5.211

7.  Detection of soluble ST2 in human follicular fluid and luteinized granulosa cells.

Authors:  Jennifer H Southcombe; Nathalie Lédée; Sophie Perrier d'Hauterive; Karen Turner; Tim Child; James V Snider; Christopher W G Redman; Ian L Sargent; Ingrid Granne
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.